Stockscreener 앱 받기
2.27
0.89%
0.02
시간 외 거래:
2.27
전일 마감가:
$2.25
열려 있는:
$2.27
하루 거래량:
4.53M
Relative Volume:
1.46
시가총액:
$253.42M
수익:
$1.88B
순이익/손실:
$-534.51M
주가수익비율:
-0.4409
EPS:
-5.1483
순현금흐름:
$4.76M
1주 성능:
-14.98%
1개월 성능:
-27.71%
6개월 성능:
-74.55%
1년 성능:
-75.67%
1일 변동 폭
$2.19
$2.34
1주일 범위
$2.19
$2.815
52주 변동 폭
$2.19
$12.06
Evolent Health Inc Stock (EVH) Company Profile
명칭
Evolent Health Inc
전화
571-389-6000
주소
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, BTSG, TEM, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
2.27 | 251.19M | 1.88B | -534.51M | 4.76M | -5.1483 |
VEEV
Veeva Systems Inc
|
178.11 | 29.44B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
44.82 | 8.32B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
46.76 | 8.73B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
82.47 | 6.94B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.14 | 4.61B | 1.10B | 112.09M | 283.19M | 0.6096 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-11-13 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | 개시 | Needham | Buy |
| 2024-12-03 | 재확인 | BTIG Research | Buy |
| 2024-11-08 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | 개시 | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | 업그레이드 | Truist | Hold → Buy |
| 2024-04-22 | 개시 | Citigroup | Buy |
| 2024-03-01 | 개시 | Oppenheimer | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-06 | 개시 | JMP Securities | Mkt Outperform |
| 2023-10-16 | 개시 | UBS | Buy |
| 2023-04-12 | 개시 | Stephens | Overweight |
| 2022-11-01 | 개시 | Truist | Hold |
| 2022-07-29 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-30 | 개시 | Guggenheim | Buy |
| 2021-11-18 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-04-29 | 재개 | JP Morgan | Neutral |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-07-06 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-06-02 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | 재개 | Leerink Partners | Outperform |
| 2018-06-04 | 개시 | Piper Jaffray | Overweight |
| 2018-04-24 | 재개 | JP Morgan | Neutral |
| 2017-09-20 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | 개시 | Robert W. Baird | Outperform |
| 2017-03-14 | 개시 | Oppenheimer | Outperform |
| 2017-01-13 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | 재개 | JP Morgan | Overweight |
| 2016-08-05 | 재확인 | FBR Capital | Outperform |
| 2016-07-26 | 개시 | Jefferies | Buy |
| 2016-07-13 | 재확인 | FBR Capital | Outperform |
| 2016-03-29 | 개시 | FBR Capital | Outperform |
| 2016-01-06 | 개시 | Canaccord Genuity | Buy |
| 2015-06-30 | 개시 | Goldman | Buy |
| 2015-06-30 | 개시 | JP Morgan | Overweight |
| 2015-06-30 | 개시 | Leerink Partners | Outperform |
| 2015-06-30 | 개시 | Sun Trust Rbsn Humphrey | Buy |
모두보기
Evolent Health Inc 주식(EVH)의 최신 뉴스
Aug Setups: How sensitive is Evolent Health Inc to inflation2026 EndofMonth & Growth Focused Entry Point Reports - baoquankhu1.vn
Will Evolent Health Inc benefit from geopolitical trendsEarnings Risk Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Macro: How does Evolent Health Inc score in quality rankings2026 Decliners & Expert Verified Movement Alerts - baoquankhu1.vn
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Small-Cap Stock Risks: Declining Demand at Luxfer & Financial Strain at Evolent HealthNews and Statistics - IndexBox
Evolent announces appointment of Archie Mayani as chief product officer - The AI Journal
Evolent Health Appoints New Chief Product Officer - Intellectia AI
Doctor behind Cityblock joins Foodsmart to expand food as medicine for Medicaid - Stock Titan
Evolent Health at Oppenheimer Conference: Strategic Growth and Financial Focus - Investing.com Canada
EVH: Strong pipeline, conservative guidance, and focus on profitability drive growth outlook - TradingView
Fund Flows: What is the next catalyst for Evolent Health Inc2026 Review & Pattern Based Trade Signal System - baoquankhu1.vn
Forecast Cut: Is Evolent Health Inc currently under institutional pressure2026 Technicals & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Eventide Asset Management LLC Purchases 2,205,659 Shares of Evolent Health, Inc $EVH - MarketBeat
8 Knots Management LLC Lowers Position in Evolent Health, Inc $EVH - MarketBeat
Investor Alert: Unprofitable Companies with High Financial Risk in 2026News and Statistics - IndexBox
Evolent Health downgraded at KeyBanc on EBITDA recovery concerns - MSN
Evolent Health (NYSE:EVH) Shares Cross Below 50-Day Moving AverageHere's What Happened - MarketBeat
Aug Analyst Calls: What is Evolent Health Incs 5 year growth outlookQuarterly Portfolio Review & Weekly Watchlist of Top Performers - baoquankhu1.vn
Evolent Health, American Oncology Network Partner to Streamline Cancer Care - MSN
Gainers Report: How sensitive is Evolent Health Inc to inflationMarket Activity Summary & AI Forecasted Entry/Exit Points - baoquankhu1.vn
How Evolent Health Inc Class stock expands through international markets2026 Macro Impact & Verified Trade Idea Suggestions - Naître et grandir
Precision Trading with Evolent Health Inc Class A (EVH) Risk Zones - Stock Traders Daily
How The Evolent Health (EVH) Investment Story Is Shifting After Reserves Reset And Higher Leverage - Yahoo Finance
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Profit Recap: Is Madison Square Garden Entertainment Corp stock influenced by commodity pricesWeekly Trend Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Evolent Health (NYSE: EVH) CEO reports PSU grant and tax-withheld share dispositions - Stock Titan
Evolent Health (EVH) president awarded PSUs and withholds shares for taxes - Stock Titan
Evolent Health (EVH) CAO awarded PSUs while shares withheld for taxes - Stock Titan
Evolent Health (EVH) CFO awarded 429,041 performance share units tied to 2027–2029 stock goals - Stock Titan
Evolent Health (NYSE: EVH) GC logs PSU grant and tax-share withholdings - Stock Titan
EVH Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Cowen Maintains Buy on Evolent Health (EVH) March 2026, PT Cut to $7 - Meyka
TD Cowen cuts Evolent Health stock price target to $7 on 2026 outlook - Investing.com Canada
Oppenheimer Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Evolent Health (EVH) Receives Updated Analyst Rating from Oppenh - GuruFocus
Oppenheimer Adjusts Evolent Health Price Target to $6 From $12, Maintains Outperform Rating - marketscreener.com
Evolent Health Charts Growth Amid 2026 Margin Squeeze - TipRanks
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Wall Street Zen Upgrades Evolent Health Stock Rating - National Today
Evolent Health (NYSE:EVH) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Evolent Health and iRhythm Shares Are Falling, What You Need To Know - Yahoo Finance
EVH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Evolent Health Inc affected by consumer sentimentTrade Risk Assessment & Risk Managed Investment Signals - baoquankhu1.vn
Evolent to Participate in Upcoming Investor Conferences - The Malaysian Reserve
Evolent Health price target lowered to $4 by Citigroup - National Today
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Evolent Health (NYSE:EVH) Price Target Lowered to $4.00 at Citigroup - MarketBeat
UBS Maintains Evolent Health (EVH) Rating, Lowers Price Target | - GuruFocus
UBS Group Lowers Evolent Health (NYSE:EVH) Price Target to $5.00 - MarketBeat
Privia Health Group, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Evolent Health: Cheap, Levered, But Ready To Rebound (NYSE:EVH) - Seeking Alpha
Evolent Health Inc (EVH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.33%
5.55%
자본화:
|
볼륨(24시간):